Live
- Bullets fired at moving train in Bhadrak
- Realme GT 7 Pro: Launch, Price, Features & Specifications
- Satyadev’s ‘Zebra’ unveils melodic first single ‘Meri Teri’
- Director Srinu Vaitla extends his wishes to ‘Dhoom Dhaam’
- Bellamkonda Sai Sreenivas stuns in intense FL of ‘Bhairavam’
- ‘Esaaraina’ set to hit theaters on Nov 8
- Truecaller Earns Triple ISO Certification
- MP Kesineni Sivanath reviews on development of NTR district, outlines initiatives
- World Bank to support farmers of Kerala to adapt climate impacts
- ISL 2024-25: FC Goa eager to continue momentum against in-form Punjab FC
Laurus Labs' Q2 net profit at Rs 57 crore
Laurus Labs Ltd on Friday announced that its total revenue grew by 21 per cent to Rs 712 crore against Rs 588 crore during Q2 FY' 19.
Hyderabad: Laurus Labs Ltd on Friday announced that its total revenue grew by 21 per cent to Rs 712 crore against Rs 588 crore during Q2 FY' 19.
The city-based drug-maker said, profit after tax (PAT) for the quarter ended September 30, 2019 was up by 249 per cent to Rs 56.6 crore against Rs 16.2 crore during the corresponding period last fiscal.
Satyanarayana Chava, CEO, Laurus Labs said, "the performance during the quarter shows the ability to execute the long-term strategy of the company with enhanced revenue from formulations business contributing positively to both topline and margins."
He further said: "We have recorded robust growth across most of our divisions.
The API (active pharmaceutical ingredient) division showed a strong growth during the quarter on the back of increase in new product additions, with oncology and synthesis maintaining their growth momentum."
